Want to join the conversation?
Jami Rubin of Goldman Sachs asks about revenue and earnings growth going forward. $AGN said the sale of the Anda business will conclude its transformation efforts. The company has good broadbased revenue growth and is in a strong sales position with healthy margins. $AGN is focused on improving earnings and is confident of achieving the same.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.